Evangel Pharmaceuticals Private Limited
About Evangel Pharmaceuticals Private Limited
Data last updated:
Evangel Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 27 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74990WB2018PTC228161. Its GSTIN is 19AAFCE2105E1Z4 (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Amit Daloi and Arpita Saha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 Ram Narayan Mukherjee Road Sarsuna, Kolkata, West Bengal, India – 700061.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.53 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Lakh (net margin 0.7%) and EBITDA of ₹1.99 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years.
The company has about 19 employees on its provident fund (EPFO) records.
Company details
Contact details
Evangel Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address24 Ram Narayan Mukherjee Road Sarsuna, Kolkata, West Bengal, India – 700061
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Evangel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Evangel Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Evangel Pharmaceuticals Private Limited, buy the company report.
Financials of Evangel Pharmaceuticals Private Limited
FY 2025 filings availableEvangel Pharmaceuticals Private Limited reported revenue of ₹1.53 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 37% over three years, including 7% growth in the latest year. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Evangel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Evangel Pharmaceuticals Private Limited
Evangel Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Daloi | Director | 27 Sep 2018 | 8 Years 1 Months | Current |
| Arpita Saha | Director | 27 Sep 2018 | 8 Years 1 Months | Current |
| Rajesh Saha | Director | 27 Sep 2018 | 8 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Evangel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evangel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Evangel Pharmaceuticals Private Limited has a workforce of 19 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Evangel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAFCE2105E1Z4 | West Bengal | Active | 21 Aug 2019 |
To see the full GST registrations and return filing status of Evangel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Evangel Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Amit Daloi was appointed as Director on 27 Sep 2018.
Frequently asked questions
Evangel Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in other services, within the business services industry. It was incorporated on 27 September 2018 (8+ years old) and is registered under CIN U74990WB2018PTC228161.
Evangel Pharmaceuticals has 3 current directors:
- Amit Daloi - Director
- Arpita Saha - Director
- Rajesh Saha - Director
The latest financial statements of Evangel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Evangel Pharmaceuticals is 19AAFCE2105E1Z4, registered in West Bengal.
The CIN (Corporate Identification Number) of Evangel Pharmaceuticals is U74990WB2018PTC228161. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evangel Pharmaceuticals was incorporated on 27 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.
Amit Daloi was appointed as Director on 27 Sep 2018. Arpita Saha was appointed as Director on 27 Sep 2018. Rajesh Saha was appointed as Director on 27 Sep 2018.
The registered office of Evangel Pharmaceuticals is at 24 Ram Narayan Mukherjee Road Sarsuna, Kolkata, West Bengal, India – 700061.
Evangel Pharmaceuticals operates in the business services industry, in the other services segment.
Evangel Pharmaceuticals can be reached at its registered office: 24 Ram Narayan Mukherjee Road Sarsuna, Kolkata, West Bengal, India – 700061.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
